Disease/Infection News

RSS

World’s only Atomo HIV Self Test receives CE Marking from European Union Notified Body

Atomo Diagnostics, a world leader in innovative point-of-care, rapid diagnostic devices, announced today that its Atomo HIV Self Test has been granted CE Marking by a European Union Notified Body.

12 Oct 2017

Ebola vaccine that provides a year’s worth of protection developed

Liberia’s Ebola outbreak has yielded a successful trial of two vaccines against the deadly infection that could provide protection for up to a year and is also deemed to be safe.

12 Oct 2017

New research reveals negative consequences of coffee cultivation in Uganda

New research led by Kelly Austin, associate professor of sociology at Lehigh, explores unequal exchange in the coffee industry. She cites a range of negative consequences that coffee cultivation contributes to, including: malaria vulnerability, decreased participation in schooling, gender inequalities, and environmental degradation in Bududa, Uganda.

11 Oct 2017

Study reveals unique norovirus characteristic of hiding from host immune system

Noroviruses are the leading cause of non-bacterial gastroenteritis in the world and are estimated to cause 267 million infections and 20,000 deaths each year. This virus causes severe diarrhea, nausea, and stomach pain.

11 Oct 2017

Scientists better understand how rabies virus induces drastic changes in behavior

Scientists may finally understand how the rabies virus can drastically change its host's behavior to help spread the disease, which kills about 59,000 people annually.

11 Oct 2017

TB Alliance announces phase 1 clinical trials of two novel tuberculosis drugs

TBA-7371 and sutezolid entered phase 1 clinical trials, TB Alliance announced today. Both compounds have proceeded through early preclinical development and were granted "Investigative New Drug" status by the U.S. Food and Drug Administration. The phase 1 clinical trials are presently ongoing.

11 Oct 2017

New serotypes of Zika virus could appear in near future, researcher cautions

Zika virus is mutating so fast in Brazilian patients that different serotypes of the pathogen could appear in the near future, as is already the case with dengue virus. This would hinder the production of a vaccine and impair the effectiveness of the diagnostic tests already developed.

10 Oct 2017

Trial reveals value of tuberculosis chemoprophylaxis in HIV-infected people

Long-term follow-up in the ANRS TEMPRANO trial confirms that tuberculosis chemoprophylaxis in HIV-infected people is more than ever relevant in resource-limited countries.

10 Oct 2017

TTUHSC El Paso researcher receives $420,000 grant to study mosquito-borne Zika virus

Haoquan Wu, Ph.D., associate professor in the Paul L. Foster School of Medicine, has received a two-year, $420,000 grant from the National Institute of Allergy and Infectious Disease to study the mosquito-borne virus Zika.

10 Oct 2017

GW researchers receive NIH award to bring Zika vaccine trial to Brazil

The National Institute of Allergy and Infectious Disease of the National Institutes of Health awarded more than $2 million to a research team at the George Washington University School of Medicine and Health Sciences to facilitate a Zika vaccine trial in Brazil.

9 Oct 2017

Study finds abundant disease-transmitting mosquito species in deforested areas

Most disease-transmitting mosquito species live in deforested areas, a finding that may influence decisions on where and when to cut down trees, a new University of Florida study shows.

9 Oct 2017

Patients with documented penicillin allergy more likely to develop surgical site infections, study finds

A study by Massachusetts General Hospital investigators found that surgical patients believed to be allergic to penicillin were significantly more likely to develop surgical site infections than were patients with no documented allergy, a difference totally attributable to the alternative antibiotics used to prevent such infections.

9 Oct 2017

WHO delivers 1.2 million doses of antibiotics to prevent, treat plague in Madagascar

WHO has delivered nearly 1.2 million doses of antibiotics and released US$1.5 million dollars in emergency funds to fight plague in Madagascar

9 Oct 2017

Antibiotics prescribed by dentists may contribute to serious C. diff infections

Antibiotics prescribed by dentists may contribute to the growing problem of Clostridium difficile (C. diff), a serious and potentially deadly infection that causes severe diarrhea, suggests research presented at IDWeek 2017. And many of those antibiotics are likely unnecessary, researchers note.

6 Oct 2017

Penn study explains how acute viral infections can linger

Infections caused by viruses, such as respiratory syncytial virus, or RSV, measles, parainfluenza, and Ebola, are typically considered acute. These viruses cause disease quickly and live within a host for a limited time. But in some cases, the effects of the infection, and presence of the virus itself, can persist.

6 Oct 2017

Ebola vaccine found to be safe and effective for adults and children in Africa

Experts at St George's, University of London, have reported that an Ebola vaccine is safe for children as well as adults and produces an immune response.

6 Oct 2017

New antifungal drug developed to help in treatment of invasive fungal infections

University of Liverpool researchers, working with F2G Limited (Eccles, Manchester), have developed a new antifungal drug to help in the treatment of life threatening invasive fungal infections such as invasive aspergillosis.

6 Oct 2017

FDA grants approval for new test to detect Zika virus in blood donations

The U.S. Food and Drug Administration today approved the cobas Zika test, a qualitative nucleic acid test for the detection of Zika virus RNA in individual plasma specimens obtained from volunteer donors of whole blood and blood components, and from living organ donors.

6 Oct 2017

Researchers uncover promising targets for development of drugs against leishmaniasis

Brazilian researchers at the University of São Paulo's Bioscience Institute (IB-USP) are starting to unravel the molecular mechanisms by which the parasite that causes cutaneous leishmaniasis manages to circumvent the host organism's defenses and infect new cells.

5 Oct 2017

JAX professor receives $2.8 million New Innovator Award for skin microbiome research

Julia Oh, Ph.D., a Jackson Laboratory (JAX) assistant professor who explores the communities of microorganisms that live on the human skin, has received a special New Innovator Award of $2,835,000 from the National Institutes of Health (NIH) to explore how to develop engineered probiotic treatments for a variety of skin and infectious diseases.

5 Oct 2017

Disease/Infection News

World’s only Atomo HIV Self Test receives CE Marking from European Union Notified Body

Ebola vaccine that provides a year’s worth of protection developed

New research reveals negative consequences of coffee cultivation in Uganda

Study reveals unique norovirus characteristic of hiding from host immune system

Scientists better understand how rabies virus induces drastic changes in behavior

TB Alliance announces phase 1 clinical trials of two novel tuberculosis drugs

New serotypes of Zika virus could appear in near future, researcher cautions

Trial reveals value of tuberculosis chemoprophylaxis in HIV-infected people

TTUHSC El Paso researcher receives $420,000 grant to study mosquito-borne Zika virus

GW researchers receive NIH award to bring Zika vaccine trial to Brazil

Study finds abundant disease-transmitting mosquito species in deforested areas

Patients with documented penicillin allergy more likely to develop surgical site infections, study finds

WHO delivers 1.2 million doses of antibiotics to prevent, treat plague in Madagascar

Antibiotics prescribed by dentists may contribute to serious C. diff infections

Penn study explains how acute viral infections can linger

Ebola vaccine found to be safe and effective for adults and children in Africa

New antifungal drug developed to help in treatment of invasive fungal infections

FDA grants approval for new test to detect Zika virus in blood donations

Researchers uncover promising targets for development of drugs against leishmaniasis

JAX professor receives $2.8 million New Innovator Award for skin microbiome research

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest News